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Epidemiological studies have identified several factors that are likely to have a major effect on
reducing rates of cancer: reduction of smoking, increased consumption of fruits and vegetables,
and control of infections. Other factors include avoidance of intense sun exposure, increased
physical activity, and reduced consumption of alcohol and possibly red meat. Risks of many types
of cancer can already be reduced, and the potential for further reductions is great. In the United
States, cancer death rates for all cancers combined are decreasing, if lung cancer (90% of which
is due to smoking), is excluded from the analysis. We review the research on causes of cancer
and show why much cancer is preventable. The idea that traces of synthetic chemicals, such as
DDT, are major contributors to human cancer is not supported by the evidence, yet public
concern and resource allocation for reduction of chemical pollution are very high, in part because
standard risk assessment uses linear extrapolation from limited data in high-dose animal cancer
tests. These tests are done at the maximum tolerated dose (MTD) and are typically misinter-
preted to mean that low doses of synthetic chemicals and industrial pollutants are relevant to
human cancer. About half the chemicals tested, whether synthetic or natural, are carcinogenic to
rodents at such high doses. Almost all chemicals in the human diet are natural. For example,
99.99% of the pesticides we eat are naturally present in plants to ward off insects and other
predators. Half of the natural pesticides that have been tested at the MTD are rodent
carcinogens. Cooking food produces large numbers of natural dietary chemicals. Roasted coffee,
for example, contains more than 1000 chemicals: of 27 tested, 19 are rodent carcinogens.
Increasing evidence supports the idea that the high frequency of positive results in rodent
bioassays is due to testing at the MTD, which frequently can cause chronic cell killing and
consequent cell replacement-a risk factor for cancer that can be limited to high doses. Because
default risk assessments use linear extrapolation, which ignores effects of the high dose itself,
low-dose risks are often exaggerated. Environ Health Perspect 105(Suppl 4):865-873 (1997)
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Cancer Trends
According to the National Cancer Institute's and about 530,000 deaths in the United
1993 Surveillance, Epidemiology, and End States in 1993. Four major cancers-lung,
Results Program (1), cancer caused 23% of colon-rectum, breast, and prostate-
the person-years ofpremature loss of life accounted for 55% ofthese deaths. Cancer
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death rates in the United States are decreas-
ing, after adjustment for age and exclusion of
lung cancer. The age-adjusted mortality rate
for all cancers combined (excluding lung and
bronchus) has declined 14% from 1950 to
1990. Smoking, in addition to causing 90%
oflung cancer, contributes to cancers ofthe
mouth, esophagus, pancreas, bladder, and
possibly colon; if these were taken into
account, the dedinewould be greater.
Peto and colleagues (2) have come to
the same conclusion: "The common belief
that there is an epidemic of death from
cancer in developed countries is a myth,
except for the effects of tobacco. In many
countries cancer deaths from tobacco are
going up, and in some they are at last com-
ing down. But, ifwe take away the cancer
deaths that are attributed to smoking then
the cancer death rates that remain are, if
anything, declining."
The number ofpeople newly diagnosed
with cancer (incidence rate) has been
increasing for some types of cancer. In
their comprehensive study on the causes of
cancer, Doll and Peto (3) point out that
incidence rates should not be taken in iso-
lation because reported incidence rates for
a disease might reflect increases in registra-
tion ofcases and improvements in diagno-
sis. For example, the rapid increase in
age-adjusted prostate cancer incidence
without any major increases in mortality is
mostly due to increased screening and inci-
dental detection during prostatectomy for
benign prostatic hypertrophy (4). Devesa
et al. (5) discuss incidence and mortality
trends by site in detail.
Major Contributors
to Risk ofCancer
Two critical factors in the formation of
mutations are lesions in DNA (produced
when DNA is damaged) and cell division
(which converts DNA lesions to muta-
tions). Agents that increase either lesions or
cell division in stem cells can increase muta-
tions, and as a consequence increase cancer
incidence (below) (4,6-8). Hormones stim-
ulating cell division increase cancer inci-
dence (e.g., estrogen in breast cancer and
testosterone in prostate cancer); hormones
may be a risk factor in about 20% of
human cancer (4,6).
OxidativeDamageandthe
DegenerativeDiseasesofAging
Aging and its degenerative diseases appear
to be due in good part to the accumulation
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of oxidative damage to DNA and.other
macromolecules (9). By-products of nor-
mal metabolism-superoxide, hydrogen
peroxide, and hydroxyl radical-are the
same oxidative mutagens produced by radi-
ation (10). Oxidative lesions in DNA
accumulate with age, so that by the time a
rat is old (2 years) it has about 1 million
DNA lesions per cell, which is about twice
the number in a young rat (9). Mutations
also accumulate with age. DNA is oxidized
in normal metabolism because antioxidant
defenses, though numerous, are not per-
fect. Endogenously produced oxidants can
damage proteins as well as DNA (11). In
two human diseases associated with prema-
ture aging, Werner's syndrome and pro-
geria, oxidized proteins accumulate at a
much higher rate than normal (11).
Chronic inflammation from chronic
infection results in release of oxidative
mutagens from phagocytic cells and is a
major contributor to cancer (below).
Antioxidant defenses against oxidative
damage include vitamins C and E and
carotenoids. To the extent that the major
external risk factors for cancer-smoking,
unbalanced diet, and chronic inflamma-
tion-are diminished, cancer will appear at
a later age, and the proportion of cancer
that is caused by normal metabolic processes
will increase.
Diet
Doll and Peto (3) and others (6) estimate
that diet accounts for about one-third of
cancer risk, and current research is slowly
clarifying specific factors.
Cancer Prevention by Calorie or
Protein Restriction. In rodents, a calorie-
restricted diet compared to ad libitum
feeding markedly decreases tumor inci-
dence and increases life span (12-14).
Protein restriction appears to have a simi-
lar effect on rodents, although research is
less extensive (15). An understanding of
mechanisms for the marked effect of
dietary restriction on aging and cancer is
becoming clearer and may be due largely
to reduced oxidative damage and reduced
rates of cell division. Although epidemio-
logical evidence on restriction in humans
is sparse, the possible importance of
growth restriction in human cancer is sup-
ported by epidemiological studies that
indicate higher rates of breast cancer
among taller persons (16,17). For exam-
ple, Japanese women are now taller, men-
struate earlier, and have increased breast
cancer rates. Also, many of the variations
in breast cancer rates among countries and
trends over time within countries are
compatible with changes in growth rates
and attained adult height (18).
Cancer Prevention by Dietary Fruits
and Vegetables. Adequate consumption of
fruits and vegetables is associated with a
lowered risk ofdegenerative diseases such
as cancer, cardiovascular disease, cataracts,
and brain and immune dysfunction (9).
Nearly 200 studies in the epidemiological
literature have been reviewed, and they
show a consistent association between inad-
equate consumption of fruits and vegeta-
bles and cancer (19-21). The quarter of
the population with the lowest dietary
intake of fruits and vegetables has roughly
twice the cancer risk for most types of
cancer (lung, larynx, oral cavity, esophagus,
stomach, colon and rectum, bladder, pan-
creas, cervix, and ovary) compared with the
quarter with the highest intake. For hor-
monally related cancers, the protective
effect ofconsuming fruits and vegetables is
weaker and less consistent: for breast cancer
the protective effect appears to be about
30% (16,19,22). Laboratory studies suggest
that antioxidants such as vitamins C and E
and carotenoids account for a good part of
the beneficial effect offruits and vegetables
(9); however, epidemiologists have diffi-
culty disentangling the effects of dietary
intakes of the antioxidants from other
important vitamins and ingredients in fruits
and vegetables (23,24).
A wide array of compounds in fruits
and vegetables in addition to antioxidants
may contribute significantly to the reduc-
tion of cancer. Folic acid may be particu-
larly important. Lowfolic acid intake causes
chromosome breaks in rodents (25) and in
humans (26,27) and increases tumor inci-
dence in some rodent models (28). Folic
acid is essential for the synthesis of DNA.
Low folate intake has been associated with
several neoplasms including adenomas and
cancers of the colon (29-31). Maternal
deficiency offolate is associated with neural
tube birth defects (32). Deficient intake of
folic acid is common in U.S. diets. About
15% of the U.S. population (33) has a
folate level atwhich chromosome breaks are
seen (26). A study ofadolescents (34) and
elderly (35) from urban, low-income, pre-
dominantly African-American households,
found that about half had such levels.
Dietary fiber, obtained only from foods of
plant origin, may contribute to lower risk
ofcolon cancer (36). Plant foods also con-
tain a wide variety ofweak estrogens that
may act as antiestrogens by competing with
estrogenic hormones (20,24,37).
Other Aspects of Diet. Although
epidemiological studies most clearly support
the benefits offruits and vegetables in the
prevention ofcancer, strong international
correlations suggest that animal (but not
vegetable) fat and red meat may increase
the incidence of cancers of the breast,
colon, and prostate (38). However, large
prospective studies have consistently shown
either a weak association or a lack ofassoci-
ation between fat intake and breast cancer
(16). Consumption ofanimal fat and red
meat have been correlated with risk of
colon cancer internationally, but the rela-
tion with fat intake has not been supported
in most case-control and cohort studies
(39,40); the association with meat con-
sumption appears more consistent (40-43).
Consumption of animal fat and red meat
has been associated with risk of prostate
cancer (42,44). Mechanisms for these asso-
ciations are not clear, but may include the
effects ofdietary fats on endogenous hor-
mone levels (4), the local effects of bile
acids on the colonic mucosa, the effects of
carcinogens produced by cooking meat,
and excessive iron intake from red meat.
Excess iron absorption, particularly heme
iron from meat, is a plausible, though
unproven, contributor to the production of
oxygen radicals (9). Some ofthe large geo-
graphical differences in colon cancer rates
that have been attributed to dietary factors
are probably due to differences in physical
activity, which is inversely related to colon
cancer risk in manystudies (45-47).
Alcoholic beverages cause inflammation
and cirrhosis of the liver, leading to liver
cancer (48). Alcohol is an important cause
of oral and esophageal cancer and is also
synergistic with smoking (48) and possibly
contributes to colorectal cancer (31,49).
Cooking food is plausible as a contrib-
utor to cancer (50). Cooking forms a wide
variety of chemicals. Four groups of
chemicals that cause tumors in rodents have
attracted attention because ofmutagenicity,
potency, or concentration: nitrosamines,
heterocyclic amines, polycyclic hydrocar-
bons, and furfural and similar furans.
Epidemiological studies on cooking are dif-
ficult and so far are inadequate to evaluate a
carcinogenic effect in humans (51).
Tobacco
Smoking contributes to about one-third of
cancer, about one-quarter ofheart disease,
and about 400,000 premature deaths per
year in the United States (52). Tobacco is
a known cause ofcancer ofthe lung, blad-
der, mouth, pharynx, pancreas, stomach,
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larynx, esophagus (2), and possibly colon
(53-55). Tobacco causes even more deaths
by diseases other than cancer. The evidence
for environmental tobacco smoke as a
cause of cancer is much weaker. Studies
have estimated that environmental tobacco
smoke causes up to 3000 additional cases
of cancer a year (56,57), although this
estimate has been disputed (58).
The carcinogenic mechanisms of
tobacco smoking are not well understood.
Smoke contains a wide variety ofmutagens
and rodent carcinogens, and smoking is a
severe oxidative stress and causes in-
flammation in the lung. The oxidants in
cigarette smoke-mainly nitrogen oxides-
deplete the body's antioxidants. Thus,
smokers must ingest two to three times
more ascorbate than nonsmokers to achieve
the same level ofascorbate in blood, but
they rarely do (59-61). Men with inade-
quate diets or who smoke may damage
both their somatic DNA and the DNA of
their sperm. When the level of dietary
ascorbate is insufficient to keep seminal
fluid ascorbate at an adequate level, the
oxidative lesions in sperm DNA are
increased 2.5 times (62). Inadequate con-
centration ofascorbate in plasma is more
common among single males, the poor, and
smokers (63). Paternal smoking may plau-
sibly increase the risk ofbirth defects and
childhood cancer in offspring (64).
C cerfromInflammadon
CausedbyChronicInfection
White cells and other phagocytic cells of
the immune system combat bacteria, para-
sites, and virus-infected cells by destroying
them with potent mutagenic oxidizing
agents. The oxidants protect humans from
immediate death from infection; but they
also cause oxidative damage to DNA,
mutation, and chronic cell killing with
compensatory cell division (65,66) and
thus contribute to the carcinogenic process.
Antioxidants appear to inhibit some ofthe
pathology ofchronic inflammation (9).
We estimate that chronic infections
contribute to about one-third of the
world's cancer. Hepatitis B and C viruses
are a major cause ofchronic inflammation
leading to liver cancer-one ofthe most
common cancers in Asia and Africa
(67-69). Hepatitis B and C viruses infect
about 500 million people worldwide.
Nearly halfthe world's liver cancer occurs
in China (70). Vaccinating babies at birth
is potentially an effective method to reduce
liver cancer and is routinely done for
hepatitis B in Taiwan. The mutagenic
mold toxin, aflatoxin, which is found in
moldy peanut and corn products, interacts
with chronic hepatitis infection in liver
cancer development (71-73).
Another major chronic infection is
schistosomiasis, which is widespread
in Egypt and Asia. In Egypt, the eggs
of Schistosoma haematobium, deposited
in the bladder, cause inflammation and
bladder cancer (74). In Asia, the eggs of
Schistosomajaponicum, deposited in the
colonic mucosa, cause inflammation, and
there is limited epidemiological evidence
for an association with colon cancer (74).
Opisthorchis viverrini, a liver fluke, infects
millions of people in Thailand and
Malaysia. The flukes lodge in bile ducts
and increase the risk of cholangiocarci-
noma (74). Chlonorchis sinensis infects
millions ofpeople in China and increases
the risk for biliary tract cancer (74).
Helicobacterpylori bacteria, which infect
the stomachs ofmore than one-third ofthe
world's population, are a major cause of
stomach cancer, ulcers, and gastritis (74).
In the United States the infection is often
asymptomatic, which suggests that inflam-
mation may be at least partially suppressed,
possibly by adequate levels of dietary
antioxidants (75).
Human papilloma virus, a major risk
factor for cervical cancer, does not appear
to work through an inflammatory mecha-
nism (76). It is spread by sexual contact,
an effective method oftransmitting viruses.
Chronic inflammation resulting from
noninfectious sources can also lead to can-
cer. For example, asbestos exposure leading
to chronic inflammation may be in good
part the reason that asbestos is a significant
riskfactor forlung cancer (77,78).
Hormones
Henderson et al. have reviewed the extensive
literature on hormones and cancer, which
indicates that endogenous reproductive hor-
mones play a large role in cancer, possibly
contributing to as much as one-third ofall
cancer, indudingbreast, prostate, ovary, and
endometrium (4). Hormones are likely to
actbycausingcell division (79).
Less Important Contributors
to Risk ofCancer
We have discussed elsewhere some ofthe
less important contributors to cancer,
including hereditary factors, sun expo-
sure, and medical interventions (6). Here
we discuss occupation and pollution
because the scientific basis for concern
needs clarification.
Occupation
The International Agency for Research on
Cancer ofthe World Health Organization
evaluates potential cancer risks to humans
from a range ofchemical exposures (80).
Halfofthe 60 chemicals and chemical mix-
tures the agency has evaluated as having
sufficient evidence of carcinogenicity in
humans represent occupational exposures,
which tend to be concentrated among small
groups ofpeoplewho have been chronically
exposed at high levels. These include work-
place exposures such as rubber industry or
coke production, as well as exposure to spe-
cific aromatic amines, petrochemicals, and
metals. How much cancer can be attributed
to occupational exposure has been a contro-
versial issue, but a few percent seems a rea-
sonable estimate. Doll and Peto (3) have
discussed difficulties in making such esti-
mates, including the lack ofaccurate data
on the history of exposure and current
exposures, as well as confounding factors
such as socioeconomic status and smoking.
Lung cancerwas by far the largest contribu-
tor to Doll and Peto's estimate ofthe pro-
portion ofcancers due to occupation. The
preeminence ofsmoking as a cause oflung
cancer confounds the interpretation ofrates
in terms ofparticular workplace exposures
to substances such as asbestos; asbestos
appears to multiply rather than just add to
the effect ofsmoking. In contrast, asbestos
alone is a known risk factor for mesothe-
lioma. Doll and Peto (3) estimated that
asbestos caused a high proportion ofoccu-
pational cancers, but recent estimates for
asbestos-related cancer arelower (81,82).
Exposures to substances in the work-
place can be high in comparison with other
chemical exposures in food, air, or water.
Past occupational exposures have often
been high and comparatively little quanti-
tative extrapolation may be required for
risk assessment from high-dose rodent tests
to high-dose occupational exposures.
Because occupational cancer is concen-
trated among small groups exposed at high
levels, there is an opportunity to control or
eliminate risks once they are identified.
The U.S. Occupational Safety and Health
Administration (U.S. OSHA), however,
unlike other federal agencies such as the
U.S. Environmental Protection Agency
(U.S. EPA), regulates few chemicals as
potential human carcinogens. For 75 rodent
carcinogens regulated by U.S. OSHA with
permissible exposure limits, we recently
rankedpotential carcinogenic hazards on an
index that compares the permitted dose
rate for workers with the carcinogenic dose
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for rodents (83). We found that for 9
chemicals the permitted exposures were
within a factor of 10 ofthe rodent carcino-
genic dose and for 17 they were between 10
and 100 times lower. These values are high
in comparison with hypothetical risks regu-
lated by other federal agencies. An addi-
tional 120 rodent carcinogens to which
workers are exposed had no U.S. OSHA
permissible exposure limit, which suggests
the need for further regulatory attention and
research on mechanism ofcarcinogenesis.
Pollution
Much ofthe public fears synthetic pollutants
as major causes ofcancer, but this fear is
based on a misconception. Even assuming
that the U.S. EPA's worst-case risk esti-
mates for synthetic pollutants are true
risks, the proportion of cancer that the
U.S. EPA could prevent by regulation
would be tiny (84). Epidemiological
studies of pollutants, moreover, are diffi-
cult to conduct because ofinadequacies in
assessing low-level exposures and failure to
account for confounding factors like smok-
ing, diet, and geographic mobility of the
population. Since the focus ofthis section
is on cancer causation, we shall not discuss
other issues in environmental protection.
AirPollution
Indoor air is generally of greater concern
than outside air because people spend 90%
oftheir time indoors and because the con-
centrations ofpollutants indoors tend to be
higher than outdoors. Radon is likely to be
the most important carcinogenic air pollu-
tant. It occurs naturally as a radioactive gas
that is generated as a decay product ofthe
radium present in trace quantities in the
earth's crust. Radon primarily enters
houses in air that is drawn from the under-
lying soil. On the basis ofepidemiological
studies ofhigh exposures ofunderground
miners, researchers have estimated that
radon causes as many as 15,000 lung can-
cers per year in the United States, mostly
among smokers because of the synergistic
effect with smoking (85-87). Epidemio-
logical studies ofradon exposures in homes
(88,89) have failed to demonstrate con-
vincingly an excessive risk. About 50,000
to 100,000 of the homes in the United
States (0.1%) are estimated to have annual
average radon levels approximately 20
times the national average, and inhabitants
receive annual radiation doses that exceed
the current occupational standard for
underground miners. Efforts to identify
houses with high levels ofradon indicate
that they occur most frequently in concen-
trated geographic areas (90). In areas with
high levels of radon, individuals can per-
form a measurement in their homes for
about $20, and if high levels are found,
they can be reduced substantially-using
available contractors-for perhaps $1500
(86). With respect to outdoor air pollu-
tion, a recent large study has reported an
association with lung cancer when sulfates
are used as an index, but not when fine
particles are used; the study did not control
for diet (91).
WaterPollution
Water pollution as a risk factor for cancer
appears small. Among potential hazards
that have been ofconcern, the most impor-
tant are radon (exposure is small compared
to air) and arsenate. Natural arsenate is a
known human carcinogen at high doses
(92,93), and further research is needed
to determine mechanisms ofcarcinogene-
sis and the dose response in humans.
Chlorination ofwater, an important public
health intervention, produces large numbers
of chlorine-containing chemicals as by-
products, some ofwhich are rodent carcino-
gens. Evidence that chlorination ofwater
increases cancer has been judged inadequate
(94). A recent case-control interview study
did not confirm earlier associations with
bladder and colon cancer but did find an
association with rectal cancer (95).
Animal Cancer Tests and
the Rachel Carson Fallacy
Neither toxicology nor epidemiology
supports the idea that synthetic industrial
chemicals are causing an epidemic of
human cancer. Although some epidemio-
logical studies find an association between
cancer and low levels of industrial pollu-
tants, the associations are usually weak, the
results are usually conflicting, and the
studies do not correct for diet, which is a
potentially large confounding factor.
Moreover, the levels ofsynthetic pollutants
are low and rarely seem plausible as a
causal factor when compared to the back-
ground ofnatural chemicals that are rodent
carcinogens (7).
Rachel Carson's fundamental miscon-
ception was, "For the first time in the his-
tory of the world, every human being is
now subjected to contact with dangerous
chemicals, from the moment ofconception
until death" (96). She was wrong: The vast
bulk ofthe chemicals to which humans are
exposed are natural, and for every chemical
some amount is dangerous. Carson thus
lacked perspective about the wide variety of
naturally occurring chemicals to which all
people are exposed and did not address the
fact that, outside the workplace, exposures
to synthetic pollutants are extremely low
relative to the natural background.
Animal cancer tests are conducted on
synthetic chemicals at the maximum toler-
ated dose (MTD) ofthe chemical, and reg-
ulatory agencies use the results to predict
human risk at low levels ofexposure. Since
the vast proportion ofhuman exposures are
to naturally occurring chemicals, while the
vast proportion ofchemicals tested for car-
cinogenicity are synthetic, there is an
imbalance in data and perception about
chemicals and cancer.
The great bulk ofchemicals ingested by
humans is natural by both weight and
number. We estimate that 99.99% ofthe
pesticides in the diet are naturally present
in plants to ward off insects and other
predators (97). Halfthe natural pesticides
tested-35 of64-are rodent carcinogens
(7,98,99). Reducing exposure to the
0.01% of pesticides that are synthetic,
either individual chemicals or mixtures,
will not appreciably reduce cancer rates.
On the contrary, fruits and vegetables are
important for reducing cancer; making
them more expensive by reducing use of
synthetic pesticides is likely to increase
cancer. People with low incomes eat fewer
fruits and vegetables (100) and spend a
higher percentage oftheir income on food.
Humans also ingest large numbers of
natural chemicals from cooking food. Of
the more than 1000 chemicals identified in
roasted coffee, over halfofthose tested-19
of27-are rodent carcinogens (99). There
are more natural rodent carcinogens by
weight in a single cup ofcoffee than poten-
tially carcinogenic synthetic pesticide
residues in the average U.S. diet in a year,
and there are still about 1000 known chem-
icals in roasted coffee that have not been
tested. That does not necessarily mean that
coffee is dangerous, but that high-dose ani-
mal cancer tests and worst-case risk assess-
ments build in enormous safety factors and
should not be considered true risks at the
low dose ofmost human exposures.
Because of their unusual lipophilicity
and long environmental persistence, there
has been particular concern for a small
group ofpolychlorinated synthetic chemi-
cals such as DDT and polychlorinated
biphenyls. There is no convincing epidemi-
ological evidence (101), nor is there much
toxicological plausibility (7), that the levels
normally found in the environment are
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likely to contribute significandy to cancer.
TCDD, which is produced naturally by
burning when chloride ion is present, for
example in forest and other fires, and as an
industrial by-product, is an unusually
potent rodent carcinogen but seems unlikely
to be a significant human carcinogen at the
levels to which the general population
is exposed.
The reason humans can eat the
tremendous variety of rodent carcinogens
in our diet is that, like other animals, we
are extremely well protected by many gen-
eral defense enzymes, most ofwhich are
inducible-that is, whenever a defense
enzyme is in use, the body produces more
of it (102). Defense enzymes are effective
against both natural and synthetic chemi-
cals, including potentially mutagenic, reac-
tive chemicals. One does not expect, nor
does one find, a general difference between
synthetic and natural chemicals in their
ability to cause cancer in high-dose rodent
tests (7,99,103).
We have ranked possible carcinogenic
hazards from known rodent carcinogens by
using an index that relates human exposure
to carcinogenic potency in rodents (HERP)
(7,99,104,105). Our ranking does not esti-
mate risks because current science does not
have the ability to do so. Instead, we put
possible hazards ofsynthetic chemicals into
perspective against the background of nat-
urally occurring rodent carcinogens in typi-
cal portions and average exposures of
common foods (99). The residues ofsyn-
thetic pesticides or environmental pollu-
tants rank low in comparison with the
background ofnaturally occurring rodent
carcinogens, despite the fact that such a
comparison gives a minimal view ofhypo-
thetical background hazards because so few
chemicals in the natural world have been
tested for carcinogenicity in rodents. Our
results indicate that many ordinary foods
would not pass the regulatory criteria used
for synthetic chemicals. Our analysis does
not necessarily indicate that coffee con-
sumption, for example, is a significant risk
factor for human cancer even though chem-
icals in coffee have HERP values that rank
much higher in possible hazard than the
HERP that converts to the default one-in-
a-million worst-case risk estimate used by
the U.S. EPA (7). Adequate risk assessment
from animal cancer tests requires more
information about many aspects oftoxicol-
ogy, such as effects on cell division, induc-
tion of defense and repair systems, and
species differences. The U.S. EPA has
recendy given attention to these factors in
its newly proposed cancer risk assessment
guidelines (106).
More than halfthe chemicals, whether
synthetic or natural, that have been tested
at the MTD under standard testing proce-
dures are classified as carcinogenic. The
high positivity rate is consistent for syn-
thetic chemicals, natural chemicals, natural
pesticides, and chemicals in roasted coffee,
and has not changed through the years of
testing (99,107,108). Halfthe drugs in the
Physician's Desk Reference that report ani-
mal cancer test results are carcinogenic
(109). The 1969 Innes series of tests of
119 synthetic chemicals, mainly all ofthe
commonly used pesticides of the time, is
frequently cited as evidence that the pro-
portion of carcinogens in the world of
chemicals is low, as only 9% were judged
positive. Gold et al. (99,107) pointed out
that these tests were quite deficient in
power compared to modern tests, and they
have now reanalyzed Innes by asking
whether any of the Innes-negative chemi-
cals have been retested using current proto-
cols. They found that 34 had been retested
and 16 were judged carcinogenic, again
about half(99).
What is the explanation for the high
positivity rate in high-dose animal cancer
tests? When the testing protocol was devel-
oped in the 1960s, it was expected that
chemical carcinogens would be rare and
that they would be mutagens. Bias in pick-
ing more suspicious chemicals does not
appear to be the sole explanation for the
high positivity rate for numerous reasons
(107,108,110). There is, however, an expla-
nation that is supported by an increasing
arrayofpapers: that the MTD ofa chemical
can cause chronic cell killing and cell
replacement in the target tissue, a risk fac-
tor for cancer that can be limited to the
high dose. This explanation is supported
by a wide variety ofevidence. For example,
endogenous oxidative damage to DNA is
enormous-over 1 million oxidative
lesions per rat cell (9). Thus, from first
principles, the cell division rate must be a
factor in converting such lesions to muta-
tions, thereby increasing cancer. Therefore,
raising the level ofeither DNA lesions or
cell division in the cells that can give rise to
tumors will increase cancer. Just as DNA
repair protects against lesions, p53 guards
the cell cycle and protects against cell
division if the lesion level gets too high;
however, neither defense is perfect. Cell
division is also a major factor in loss ofhet-
erozygosity through nondisjunction and
other mechanisms (103,110,111).
In another line of evidence, many
studies on rodent carcinogenicity show a
correlation between cell division at the
MTD and cancer. Cunningham and col-
leagues have analyzed 15 chemicals at the
MTD, 8 mutagens and 7 nonmutagens,
including several pairs of mutagenic iso-
mers, one ofwhich is a carcinogen and one
of which is not (112-120). They have
found a perfect correlation between cancer
causation and cell division in the target tis-
sue: when tested at the bioassay dose, the
nine chemicals that cause cancer caused cell
division in the target tissue and the six
chemicals that do not cause cancer did not
cause such cell division. A similar result has
been found in an analysis ofMirsalis et al.
(121), e.g., both dimethyl nitrosamine
(DMN) and methyl methane sulfonate
(MMS) methylate liver DNA and cause
unscheduled DNA synthesis; however,
DMN causes both cell division and liver
tumors, whereas MMS does neither. The
induction of cell division at high dose
would explain why a high proportion of
the known rodent carcinogens (42%) are
not mutagenic, which is otherwise not sat-
isfactorily explained. There is a large body
ofliterature on rodent studies reviewed by
Cohen and Lawson (122), Cohen (123),
and Ames et al. (9) showing that chronic
cell division can induce cancer. Work on
chloroform induction of mouse liver
tumors by Larson et al. (124) also indi-
cates the important role ofincreased cell
division at bioassay doses. A large epidemi-
ological literature reviewed by Preston-
Martin et al. (79,125) shows that increased
cell division by hormones and other agents
can increase human cancer.
Thus it seems likely that a high propor-
tion ofthe chemicals in the world may be
carcinogens if tested in standard rodent
bioassays at the MTD; but this will be pri-
marily due to high-dose effects for nonmu-
tagens, and a synergistic effect of cell
division at high doses with DNA damage
for mutagens. Ad libitum feeding in the
standard bioassay, which also can increase
cell division, may also contribute to the
high positivity rate, as shown by a recent
National Toxicology Program study (126).
Iftumor induction in bioassays is due to
effects unique to high doses, much more
information on mechanism is required to
understand the causes ofhuman cancer.
The default risk assessment virtually safe
dose is simply a factor of740,000 times
below the MTD, as shown by Gaylor and
Gold (127). Iftests are conducted primar-
ily on synthetic chemicals and regulation is
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directed toward tiny traces ofsynthetic
chemicals, as is now the case, resources will
be diverted from more important issues.
Thus, the positivity rate and the frequency
ofpositive results that are unique to high
doses are key questions in getting an
overview of the world ofchemicals, both
natural and synthetic.
Linear extrapolation from the MTD in
rodents to low-level exposure in humans for
synthetic chemicals, while ignoring the
enormous background ofnatural chemicals,
has led to exaggerated estimates ofcancer
risk and to an imbalance in the perception
ofhazard and the allocation ofresources. If
the costs were minor, the issue ofputting
hypothetical risks into perspective would
not be so important, but the costs are great
(128,129) and escalate as cleanliness
approaches perfection. Most attempts to
deal with pollutants do not adequately deal
with trade-offs; instead, policy makers
assume that upper-bound risk assessment to
one in a million protects the public.
Reports by the Office ofManagement and
Budget (130) and the Harvard Center for
Risk Analysis (131) compared costs ofrisk
reduction among government agencies and
concluded that the money spent to save a
hypothetical life under U.S. EPA regula-
tions is often orders ofmagnitude higher
than that spent on regulations of other
government agencies. The uncertainties in
extrapolations to low-dose assessments are
great, and the true riskcould be zero. Thus,
the discrepancy between costs ofU.S. EPA
regulations and other agencies' may be even
greater, e.g., permitted worker exposure
limits regulated byU.S. OSHAcan be close
to the carcinogenic dose rate in rodent bio-
assays and little extrapolation is required.
Manyscholars have pointed out that expen-
sive regulations intended to save lives may
actually lead to increased deaths (132), in
part because they divert resources from
important health risks and in part because
higher incomes are associated with lower
mortality (133,134). Worst-case assump-
tions in risk assessment represent a policy
decision, not a scientific one, and they con-
fuse attempts to allocate money effectively
forcancer prevention (135,136).
Discussion
Epidemiological evidence in humans is
sufficient to identifyseveral broad categories
ofcancer causation for which the evidence
is strong and plausible. Because many of
those risks are avoidable, it is possible to
reduce rates ofmany types ofcancer. One
approach to estimating the population
impact ofadopting major lifestyle factors
associated with low cancer risk is to com-
pare cancer incidence and mortality rates
of the general population to those of
Seventh-Day Adventists-who generally
do not smoke, drink heavily, or eat much
meat but do eat a diet rich in fruits and
vegetables (137,138). Seventh-Day
Adventists experience substantially lower
mortality rates oflung, bladder, and colon
cancers. Total cancer mortality is about
half that of the general U.S. population.
While this comparison has limitations-
better use of medical services may con-
tribute to reduced mortality, and imperfect
compliance with recommendations may
underestimate the impact oflifestyle-the
results strongly suggest that a large portion
ofcancer deaths can be avoided by using
knowledge at hand. Incidence rates rather
than mortality rates provide a similar pic-
ture, although the differences are some-
what less. For breast cancer, the healthy
behavior ofSeventh-Day Adventists was
not sufficient to have a major effect on risk.
Decreases in physical activity, and
increases in smoking, obesity, and recre-
ational sun exposure have contributed
importantly to increases in some cancers in
the modern industrial world, whereas
improvements in hygiene have reduced
other cancers related to infection. There is
no good reason to believe that synthetic
chemicals underlie the changes in inci-
dence of some cancers. In the United
States and other industrial countries, life
expectancy has steadily increased and will
increase even faster as smoking declines.
REFERENCES
1. Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A,
Devesa SS, Edwards BK. SEER Cancer Statistics Review:
1973-1990. NIH Pub no 93-2789. Bethesda, MD:National
Cancer Institute, 1993.
2. Peto R, LopezAD, BorehamJ, Thun M, Heath CJr. Mortality
from Smoking in Developed Countries 1950-2000. Oxford:
Oxford University Press, 1994.
3. Doll R, Peto R. The causes ofcancer. Quantitative estimates of
avoidable risks of cancer in the United States today. J Natl
Cancer Inst 66:1191-1308 (1981).
4. Henderson BE, Ross RK, Pike MC. Toward the primary pre-
vention ofcancer. Science 254:1131-1138 (1991).
5. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE,
Fraumeni FJ Jr. Recent cancer trends in the United States. J
Natl Cancer Inst 87:175-182 (1995).
6. Ames BN, Gold LS, Willett WC. The causes and prevention of
cancer. Proc NatlAcad Sci USA 92:5258-5265 (1995).
7. Gold LS, Slone TH, Stern BR, Manley NB, Ames BN. Rodent
carcinogens: setting priorities. Science 258:261-265 (1992).
8. Cohen SM, Eliwein LB. Risk assessment based on high-dose ani-
mal exposure experiments. Chem ResToxicol 5:742-748 (1992).
9. Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible
DNA repair, and cell division: three key factors in mutagenesis
and carcinogenesis. Environ Health Perspect 101(Suppl
5):35-44 (1993).
10. Von Sonntag C. The Chemical Basis of Radiation Biology.
London:Taylor and Francis, 1987.
11. Stadtman ER. Protein oxidation and aging. Science
257:1220-1224 (1992).
12. Roe FJC, Lee PN, Conybeare G, Tobin G, Kelly D, Prentice
D, Matter B. Risks ofpremature death and cancer predicted by
body weight in early adult life. Hum Exp Toxicol 10:285-288
(1991).
13. Roe FJC. Non-genotoxic carcinogenesis: implications for test-
ingextrapolation to man. Mutagenesis 4:407-411 (1989).
14. Boutwel[ RK, Pariza MW. Historical perspectives: calories and
energy expenditure in carcinogenesis. Am J Clin Nutr
45(Suppl):151-156 (1987).
15. Youngman LD, ParkJ-YK, Ames BN. Protein oxidation associ-
ated with aging is reduced by dietary restriction ofprotein or
calories. Proc NatlAcad Sci USA 89:9112-9116 (1992).
16. Hunter DJ, Willett WC. Diet, body size, and breast cancer.
Epidemiol Rev 15:110-132 (1993).
17. Swanson CA, Jones DY, Schatzkin A, Brinton LA, Ziegler RG.
Breast cancer risk assessed by anthropometry in the NHANES
I epidemiological follow-up study. Cancer Res 48:5363-5367
(1988).
18. Willett WC, Stampfer MJ. Dietary fat and cancer: another
view. Cancer Causes Control 1:103-109 (1990).
19. Block G, Patterson B, Subar A. Fruit, vegetables and cancer
prevention: a review of the epidemiologic evidence. Nutr
Cancer 18:1-29 (1992).
20. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer.
I: Epidemiology. Cancer Causes Control 2:325Z357 (1991).
870 Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997CAUSES AND PREVENTION OF CANCER: GAINING PERSPECTIVE
.21. Hill MJ, Giacosa A, Caygill CPJ. Epidemiology of Diet and
Cancer. West Sussex, England:Ellis Horwood, 1994.
22. Howe GR, Hirohata T, Hislop TG. Dietary factors and risk of
breast cancer: combined analysis of 12 case-control studies. J
Natl Cancer Inst 82:561-569 (1990).
23. Block G. The data support a role for antioxidants in reducing
cancer risk. Nutr Rev 50:207-213 (1992).
24. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer.
II: Mechanisms. Cancer Causes Control 2:427-442 (1991).
25. MacGregor JT, Schlegel R, Wehr CM, Alperin P, Ames BN.
Cytogenetic damage induced by folate deficiency in mice is
enhanced by caffeine. Proc Natl Acad Sci USA 87:9962-9965
(1990).
26. Blount BC. Mack MM, Wehr CM, MacGregor JT, Hiatt RA,
Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate
deficiency causes uracil misincorporation into human DNA
and chromosome breakage: implications for cancer and neu-
ronal damage. Proc NatlAcad Sci USA 94:3290-3295 (1997).
27. Everson RB, Wehr CM, Erexson GL, MacGregor JT.
Association ofmarginal folate depletion with increased human
chromosomal damage in vivo: demonstration by analysis of
micronucleated erythrocytes. J Natl Cancer Inst 80:525-529
(1988).
28. Bendich A, Butterworth CE Jr. Micronutrients in Health and
in Disease Prevention. NewYork:Marcel Dekker, 1991;483.
29. Glynn SA, Albanes D. Folate and cancer: a review ofthe litera-
ture. Nutr Cancer 22:101-119 (1994).
30. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB,
Trichopoulos D, Rosner BA, Speizer FE, Willett WC. Folate,
methionine, and alcohol intake and risk ofcolorectal adenoma.
J Natl Cancer Inst 85:875-884 (1993).
31. Freudenheim JL, Graham S, Marshall JR, Haughey BP,
Cholewinski S, Wilkinson G. Folate intake and carcinogenesis
ofthe colon and rectum. IntJ Epidemiol 20:368-374 (1991).
32. Rush D. Periconceptional folate and neural tube defect. Am J
Clin Nutr 59:5 1S-516S (1994).
33. Senti FR, Pilch SM. Analysis of folate data from the second
National Health and Nutrition Examination Survey
(NHANES II). J Nutr 115:1398-1402 (1985).
34. Bailey LB, Wagner PA, Christakis GJ, Davis CG, AppledorfH,
Araujo PE, Dorsey E, Dinning JS. Folacin and iron status and
hematological findings in black and Spanish-American adoles-
cents from urban low-income households. Am J Clin Nutr
35:1023-1032 (1982).
35. Bailey LB, Wagner PA, Christakis GJ, Araujo PE, Appledorf
H, Davis CG, Masteryanni J, DinningJS. Folacin and iron sta-
tus and hematological findings in predominately black elderly
persons from urban low-income households. Am J Clin Nutr
32:2346-2353 (1979).
36. Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables, and
colon cancer: critical review and meta-analyses ofthe epidemio-
logic evidence. J Natl Cancer Inst 82:650-661 (1990).
37. Safe SH. Dietary and environmental estrogens and antiestro-
gens and their possible role in human disease. Environ Sci
Pollution Res 1:29-33 (1994).
38. Armstrong B, Doll R. Environmental factors and cancer inci-
dence and mortality in different countries, with special refer-
ence to dietary practices. IntJ Cancer 15:617-631 (1975).
39. Howe GR, Benito E, Castelleto R, Cornee J, Esteve J,
Gallagher RP, Iscovich JM, Jiao DA, Kaaks R, Kune GA et al.
Dietary intake of fiber and decreased risk of cancers of the
colon and rectum: evidence from the combined analysis of 13
case-control studies. J Natl Cancer Inst 84:1887-1896 (1992).
40. Willett WC. Diet, nutrition, and avoidable cancer. Environ
Health Perspect 103(Suppl 8):165-170 (1995).
41. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer
FE. Relation of meat, fat, and fiber intake to the risk ofcolon
cancer in a prospective study among women. N Engl J Med
323:1664-1672 (1990).
42. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio
A, Willett WC. Intake offat, meat, and fiber in relation to risk
ofcolon cancer in men. Cancer Res 54:2390-2397 (1994).
43. Goldbohm RA, van der Brandt PA, van 't Veer P, Brants
HAM, Dorant E, Sturmans F, Hermus RJJ. A prospective
cohort study on the relation between meat consumption and
the risk ofcolon cancer. Cancer Res 54:718-723 (1994).
44. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC,
Hirohata T. Animal fat consumption and prostate cancer: a
prospective study in Hawaii. Epidemiology 5:276-282 (1994).
45. Gerhardsson M, Floderus B, Norell SE. Physical activity and
colon cancer risk. IntJ Epidemiol 17:743-746 (1988).
46. Slattery ML, Schumacher MC, Smith KR, West DW, Abd-
Elghany N. Physical activity, diet, and risk of colon cancer in
Utah. AmJ Epidemiol 128:989-999 (1988).
47. Thun MJ, Calle EE, Namboodiri MM, Flanders WD, Coates
RJ, Byers T, Boffetta P, Garfinkel L, Heath CWJ. Risk factors
for fatal colon cancer in a large prospective study. J Natl
Cancer Inst 84:1491-1500 (1992).
48. IARC. IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans, Vol 44: Alcohol Drinking. Lyon:
International Agency for Research on Cancer, 1988.
49. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz
GA, Willett WC. Alcohol, methyl-deficient diets and risk of
colon cancer in men. J Natl Cancer Inst 87:265-273 (1995).
50. Sugimura T, Sato S, Ohgaki H, Takayama S, Nagao M,
Wakabayashi K. Genetic Toxicology of the Diet. New
York:Alan R. Liss, 1986.
51. IARC. IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans, Vol 56: Some Naturally Occurring
Substances: Food Items and Constituents, Heterocyclic
Aromatic Amines and Mycotoxins. Lyon:International Agency
for Research on Cancer, 1993.
52. Peto R, LopezAD, Boreham J, Thun M, Heath C Jr. Mortality
from tobacco in developed countries: indirect estimation from
national vital statistics. Lancet 339:1268-1278 (1992).
53. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio
A, Kearney J, Willett WC. A prospective study of cigarette
smoking and risk of colorectal adenoma and colorectal cancer
in U.S. men. J Natl Cancer Inst 86:183-191 (1994).
54. Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner
BA, Willett WC, Speizer FE. A prospective study of cigarette
smoking and risk ofcolorectal a enoma and colorectal cancer
in U.S. women. J Natl Cancer Inst 86:192-199 (1994).
55. Fielding JE. Pr&venting colon cancer: yet another reason not to
smoke. J NatI Cancer Inst 86:162-164 (1994).
56. U.S. EPA. Respiratory Health Effects of Passive Smoking:
Lung Cancer and Other Disorders. Washington:U.S.
Environmental Protection Agency, Office of Health and
Environmental Assessment, Office of Research and
Development, 1992.
57. Fontham ETH, Correa P, Reynolds P, Wu-Williams A, Buffler
PA, Greenberg RS, Chen VW, Alterman T, Boyd P, Austin DF
et al. Environmental tobacco smoke and lung cancer in non-
smoking women. JAm Med Assoc 271:1752-1759 (1994).
58. Huber G, Brockie R, Mahajan V. Smoke and mirrors: the
EPA's flawed study ofenvironmental tobacco smoke and lung
cancer. Regulation 16:44-54 (1993).
59. Schectman G, Byrd JC, Hoffmann R. Ascorbic acid require-
ments for smokers: analysis of a population survey. Am J Clin
Nutr 53:1466-1470 (1991).
60. Duthie GG, Arthur JR, James WPT. Effects ofsmoking and
vitamin E on blood antioxidant status. Am J Clin Nutr
53:1061S-1063S (1991).
61. Bui MH, Sauty A, Collet F, Leuenberger P. Dietary vitamin C
intake and concentrations in the body fluids and cells of male
smokers and nonsmokers. J Nutr 122:312-316 (1991).
62. Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob
RA, Ames BN. Ascorbic acid protects against endogenous
oxidative damage in human sperm. Proc Natl Acad Sci USA
88:11003-11006 (1991).
63. Patterson B, Block G. Fruit and vegetable consumption:
national survey data. In: Micronutrients in Health and in
Disease Prevention (Bendich A, Butterworth CEJ, eds). New
York:Marcel Dekker, 1991;409-436.
Environmental Health Perspectives - Vol 105, Supplement 4 * June 1997 871AMES AND GOLD
64. Ames BN, Motchnik PA, Fraga CG, Shigenaga MK, Hagen
TM. Antioxidant prevention ofbirth defects and cancer. In:
Male-Mediated Developmental Toxicity (Mattison DR,
Olshan A, eds). NewYork:Plenum Publishing, 1994;243-259.
65. Shacter E, Beecham EJ, Covey JM, Kohn KW, Potter M.
Activated neutrophils induce prolonged DNA damage in
neighboring cells. Carcinogenesis 9:2297-2304 (1988) [pub-
lished erratum in Carcinogenesis 10:628 (1989)].
66. Yamashina K, Miller BE, Heppner GH. Macrophage-mediated
induction ofdrug-resistant variants in a mouse mammary
tumor cell line. Cancer Res 46:2396-2401 (1986).
67. Beasley RP. Hepatitis B virus. Cancer 61:1942-1956 (1987).
68. Tabor E, Kobayashi K. Hepatitis C virus, a causative infectious
agent ofnon-A, non-B hepatitis: prevalence and structure-sum-
mary ofaconference on hepatitis C virus as a cause ofhepatocel-
lular carcinoma. J NatlCancer Inst 84:86-90 (1992).
69. Yu M-W, You S-L, Chang A-S, Lu S-N, Liaw Y-F, Chen C-J.
Association between hepatitis C virus antibodies and hepatocel-
lular carcinoma in Taiwan. Cancer Res 51:5621-5625 C1991).
70. Parkin DM, Suernsward J, Muir CS. Estimates ofthe world-
wide frequency of twelve major cancers. Bull World Health
Organ 62:163-182 (1984).
71. Qian G-S, Ross RK, Yu MC, Yuan J-M, Gao Y-T, Henderson
BE, Wogan GN, Groopman JD. A follow-up study of urinary
markers ofaflatoxin exposure and liver cancer risk in Shanghai,
People's Republic of China. Cancer Epidemiol Biomarkers
Prev 3:3-10 (1994).
72. Groopman JD, ZhuJ, Donahue PR, PikulA, Zhang L-S, Chen
JS, Wogan GN. Molecular dosimetry ofurinary aflatoxin DNA
adducts in people living in Guangxi Autonomous Region,
People's Republic ofChina. Cancer Res 52:45-51 (1992).
73. Pons WA. High pressure liquid chromatography determinations
ofaflatoxins in corn.JAssocOffAnal Chem62:584-586 (1979).
74. IARC. IARC Monographs on the Evaluation ofCarcinogenic
Risks to Humans, Vol 61: Schistosomes, Liver Flukes and
Helicobacter Pylori. Lyon:International Agency for Research
on Cancer, 1994.
75. Howson C, Hiyama T, Wynder E. The decline in gastric
cancer: epidemiology ofan unplanned triumph. Epidemiol Rev
8:1-27 (1986).
76. Lowy DR, Kirnbauer R, SchillerJT. Genital human papilloma
virus infection. ProcNadAcadSciUSA91:2436-2440(1994).
77. Korkina LG, DurnevAD, SuslovaTB, CheremisinaZP, Daugel-
Dauge NO, Afanas'ev IB. Oxygen radical-mediated mutagenic
effect ofasbestos on human lymphocytes: suppression by oxygen
radical scavengers. Mutat Res 265:245-253 (1992).
78. Marsh JP, Mossman BT. Role ofasbestos and active oxygen
species in activation and expression ofornithine decarboxylase in
hamster tracheal epithelial cells. Cancer Res 51:167-173 (1991).
79. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson
BE. Increased cell division as a cause ofhuman cancer. Cancer
Res 50:7415-7421 (1990).
80. IARC. IARC Monographs on the Evaluation ofCarcinogenic
Risks to Humans, Vol 60: Some industrial chemicals.
Lyon:International Agency for Research on Cancer, 1994.
81. Connelly RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF
Jr. Demographic patterns for mesothelioma in the United
States. J Natl Cancer Inst 78:1053-1060 (1987).
82. Reynolds T. Asbestos-linked cancer rates up less than pre-
dicted. J Natl Cancer Inst 84:560-562 (1992).
83. Gold LS, Garfinkel GB, Slone TH. Setting priorities among
possible carcinogenic hazards in the workpiace. In: Chemical
Risk Assessment and Occupational Health, Current
Applications, Limitations, and Future Prospects (Smith CM,
Christiani DC, Kelsey KT, eds). Westport, CT:Greenwood
Publishing Group, 1994;91-103.
84. Gough M. How much cancer can EPA regulate anyway? Risk
Anal 10:1-6 (1990).
85. Pershagen G, Akerblom G, Axelson 0, Clavensjo B, Damber
L, Desai G, Enflo A, Lagarde F, Mellander H, Swartengren M
et al. Residential radon exposure and lung cancer in Sweden. N
EnglJ Med 330:159-164 (1994).
86. Nero AV. A national strategy for indoor radon. Issues Sci Tech
9:33-40 (1992).
87. Lubin JH, Boice JD Jr, Elding C, Hornint RW, Howe G,
Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM et
al. Radon and lung cancer risk: a joint analysis of 11 under-
ground miner studies. NIH Publ no 94-3644. Bethesda,
MD:U.S. Department of Health and Human Services, Public
Health Service, National Institutes ofHealth, 1994.
88. Letourneau EG, Krewski D, Choi NW, Goddard MJ,
McGregor RG, Zielinski JM, DuJ. Case-control study ofresi-
dentia[ radon and lung cancer in Winnipeg, Manitoba,
Canada. AmJ Epidemiol 140:310-322 (1994).
89. Lubin JH. Lung cancer and exposure to residential radon
[Invited commentary]. AmJ Epidemiol 140:323-332 (1994).
90. Nero A. Developing a methodology for identifying high-radon
areas. Center for Building Science News (Lawrence Berkeley
Lab) 1:4-5 (1994).
91. Pope CA, Thun MJ, Namboodiri MM, Dockery DW, Evans
JS, Speizer FE, Heath CW. Particulate air pollution as a predic-
tor ofmortality in a prospective study of U.S. adults. Am J
Respir Crit Care Med 151:669-674 (1995).
92. Smith AH, Hopenhayn RC, Bates MN, Goeden HM, Hertz
PI, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer
risks from arsenic in drinking water. Environ Health Perspect
97:259-267 (1992).
93. Bates MN, Smith AH, Hopenhayn RC. Arsenic ingestion and
internal cancers: areview. AmJ Epidemiol 135:462-476 (1992).
94. IARC. IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans, Vol 52: Chlorinated Drinking-water;
Chlorination By-products; Some Other Halogenated
Compounds; Cobalt and Cobalt Compounds. Lyon:International
Agency for Research on Cancer, 1991.
95. Cantor K, Lynch C, Hildesheim M. Chlorinated drinking
water and risk ofbladder, colon, and rectal cancers: a case-con-
trol study in Iowa, USA. Epidemiology 6:S30 (1995).
96. Carson R. Silent Spring. Boston:Houghton-Mifflin, 1962.
97. Ames BN, Profet M, Gold LS. Dietary pesticides (99.99% all
natural). Proc NatlAcad Sci USA 87:7777-7781 (1990).
98. Gold LS, Slone TH, Manley NB, Garfinkel GB, Rohrbach L,
Ames BN. Carcinogenic potency database. In: Handbook of
Carcinogenic Potency and Genotoxicity Databases (Gold LS,
Zeiger E, eds). Boca Raton, FL:CRC Press, 1997;1-605.
99. Go[d LS, Slone TH, Ames BN. Overview ofanalyses of the
carcinogenic potency database. In: Handbook of Carcinogenic
Potency and Genotoxicity Databases (Gold LS, Zeiger E, eds).
Boca Raton, FL:CRC Press, 1997;661-685.
100. Patterson BH, Block G. Food choices and the cancer guide-
lines. AmJ Public Health 78:282-286 (1988).
101. Key T, Reeves G. Organochlorines in the environment and
breast cancer. BrMedJ 308:1520-1521 (1994).
102. Ames BN, Profet M, Gold LS. Nature's chemicals and syn-
thetic chemicals: comparative toxicology. Proc Natl Acad Sci
USA 87:7782-7786 (1990).
103. Ames BN, Gold LS. Chemical carcinogenesis: too many rodent
carcinogens. Proc NatlAcad Sci USA 87:7772-7776 (1990).
104. Gold LS, SloneTH, Stern BR, ManleyNB, Ames BN. Possible
carcinogenic hazards from natural and synthetic chemicals: set-
ting priorities. In: Comparative Environmental Risk
Assessment (Cothern CR, ed). Boca Raton, FL:Lewis
Publishers, 1993;209-235.
105. Gold LS, Slone TH, Manley NB, Ames BN. Heterocyclic
amines formed by cooking food: comparison ofbioassay results
with other chemicals in the carcinogenic potency database.
Cancer Lett 83:21-29 (1994).
106. U.S. Environmental Protection Agency. Proposed Guidelines for
Carcinogenic RiskAssessment. Fed Reg61:17960-18011 (1996).
107. Gold LS, Bernstein L, Magaw R, Slone TH. Interspecies
extrapolation in carcinogenesis: prediction between rats and
mice. Environ Health Perspect 81:211-219 (1989).
108. Ames BN, Gold LS. The causes and prevention ofcancer: gain-
ing perspectives on management ofrisk. In: Risks, Costs, and
Lives Saved: Getting Better Results from Regulation (Hahn
872 Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997CAUSES AND PREVENTION OF CANCER: GAINING PERSPECTIVE
RW, ed). New York/Washington:Oxford University Press/AEI
Press, 1996;4-45.
109. Davies TS, Monro A. Marketed human pharmaceuticals
reported to be tumorigenic in rodents. J Am Coll Toxicol
14:90-107 (1995).
110. Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible
DNA repair, and cell division: three key factors in mutagenesis
and carcinogenesis. Environ Health Perspect 101(Suppl
5):35-44 (1993).
111. Ames BN, Gold LS. Reply to Farber [Letter to editor]. Cancer
Res 56:4267-4274 (1996).
112. Hayward J, Shane B, Tindall K, Cunningham M. Differential
in vivo mutagenicity ofthe carcinogen/noncarcinogen pair 2,4-
and 2,6-diaminotoluene. Carcinogenesis 16:2429-2433 (1995).
113. Cunningham ML, Foley J, Maronpot R, Matthews HB.
Correlation ofhepatocellular proliferation with hepatocarcino-
genicity induced by the mutagenic noncarcinogen: carcinogen
pair-2,6- and 2,4-diaminotoluene. Toxicol Appl Pharmacol
107:562-567 (1991).
114. Cunningham ML, Matthews HB. Relationship ofhepatocar-
cinogenicity and hepatocellular proliferation induced by muta-
genic noncarcinogens vs. carcinogens. II: 1- vs. 2-nitropropane.
Toxicol Appl Pharmacol 110:505-513 (1991).
115. Cunningham ML, Elwell MR, Matthews HB. Site-specific cell
proliferation in renal tubular cells by the renal tubular carcino-
gen tris(2,3-dibromopropyl)phosphate. Environ Health
Perspect 101(Suppl 5):253-258 (1993).
116. Cunningham ML, Elwell MR, Matthews HB. Relationship of
carcinogenicity and cellular proliferation induced by mutagenic
noncarcinogens vs carcinogens. Fundam Appl Toxicol
23:363-369 (1994).
117. Cunningham ML, Maronpot RR, Thompson M, Bucher JR.
Early responses of the liver of B6C3F1 mice to the hepatocar-
cinogen oxazepam. Toxicol Appl Pharmacol 124:31-38 (1994).
118. Yarbrough J, Cunningham M, Yamanaka H, Thurman R, Badr
M. Carbohydrate and oxygen metabolism during hepatocellular
proliferation: a study in perfused livers from mirex-treated rats.
Hepatology 13:1229-1234 (1991).
119. Cunningham ML, Pippin LL, Anderson NL, Wenk ML. The
hepatocarcinogen methapyrilene but not the analog pyrilamine
induces sustained hepatocellular replication and protein alter-
ations in F344 rats in a 13-week feed study. Toxicol Appl
Pharmacol 131:216-223 (1995).
120. Thottassery J, Winberg L, YouseffJ, Cunningham M, Badr M.
Regulation of perfluorooctanoic acid-induced peroxisomal
enzyme activities and hepatocellular growth by adrenal hor-
mones. Hepatology 15:316-322 (1992).
121. Mirsalis JC, Provost GS, Matthews CD, Hamner RT,
Schindler JE, O'Loughlin KG, MacGregor JT, Short JM.
Induction of hepatic mutations in lacI transgenic mice.
Mutagenesis 8:265-271 (1993).
122. Cohen S, Lawson T. Rodent bladder tumors do not always pre-
dict for humans. Cancer Lett 93:9-16 (1995).
123. Cohen S. Human relevance of animal carcinogenicity studies.
Regul Toxicol Pharmacol 21:75-80 (1995).
124. Larson J, WolfD, Butterworth B. Induced cytotoxicity and cell
proliferation in the hepatocarcinogenicity of chloroform in
female B6C3F1 mice: comparison ofadministration by gavage
in corn oil vs ad libitum in drinking water. Fundam Appl
Toxicol 22:90-102 (1994).
125. Preston-Martin S, Monroe K, Lee P-J, Bernstein L, Kelsey J,
Henderson S, Forrester D, Henderson B. Spinal meningiomas
in women in Los Angeles County: investigation ofan etiologi-
cal hypothesis. Cancer Epidemiol Biomarkers 4:333-339
(1995).
126. National Toxicology Program. Effect of Dietary Restriction on
Toxicology and Carcinogenesis Studies in F344/N Rats and
B6C3F1 Mice. TR-460. Research Triangle Park, NC:U.S.
National Toxicology Program, 1995.
127. Gaylor DW, Gold LS. Quick estimate of the regulatory virtu-
ally safe dose based on the maximum tolerated dose for rodent
bioassays. Regul Toxicol Pharmacol 22:57-63 (1995).
128. Crandall R. Why is the cost of environmental regulation so
high? Policy Study No 110. St. Louis, MO: Center for the
Study ofAmerican Business, 1992.
129. Hahn RW. Risks, Costs, and Lives Saved: Getting Better
Results from Regulation. New York/Washington:Oxford
University Press/AEI Press, 1996.
130. OMB, Executive Office of the President. 1991-1992.
Regulatory Program of the U.S. Government. Washington:
U.S. Office ofManagement and Budget, 1992.
131. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE,
Weinstein MC, Graham JD. Five hundred life-saving interven-
tions and their cost-effectiveness. Risk Anal 15:369-390
(1995).
132. Keeney RL. Mortality risks induced by economic expenditures.
RiskAnal 10:147-159 (1990).
133. Wildavsky A. Searching for Safety. New Brunswick,
NJ:Transaction Press, 1988.
134. Viscusi WK. Fatal Trade-offs. Oxford, England:Oxford
University Press, 1992.
135. Graham J, Wiener J. Risk versus Risk: Tradeoffs in Protecting
Health and the Environment. Cambridge, MA:Harvard
University Press, 1995.
136. Breyer S. Breaking the Vicious Cycle: Toward Effective Risk
Regulation. Cambridge, MA:Harvard University Press, 1993.
137. Phillips RL, Garfinkel L, KuzmaJW, Beeson WL, Lotz T, Brin
B. Mortality among California Seventh-day Adventists for
selected cancer sites. J Natl Cancer Inst 65:1097-1107 (1980).
138. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cancer inci-
dence among California Seventh-day Adventists. Am J Clin
Nutr 59(Suppl):I136S-1142S (1994).
Environmental Health Perspectives - Vol 105, Supplement 4 * June 1997 873